CD5 CAR-NK cells can be used to accurately recognize CD5+ tumor cells and prolong T-cell acute lymphoblastic leukemia (T-ALL) xenograft mouse survival [305]. This evidence concerns the gene CD5 and acute lymphoblastic leukemia.